Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
New England Journal of Medicine · 22.10.2026 · 395 (16) · 1575-1584
DOI: 10.1056/nejmoa2608717 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 22.10.2026. Verfasst von C Michael Gibson und 59 weiteren Autor:innen. Beteiligte Einrichtung: Baim Institute for Clinical Research, Boston. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Hemorrhage, Myocardial Infarction, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Bristol-Myers Squibb, Janssen Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Baim Institute for Clinical Research, Boston.
- Harvard Medical School, Boston.
- Université Paris-Cité, Paris.
- FACT (French Alliance for Cardiovascular Trials), Paris.
- INECO Neurociencias, Rosario, Argentina.
- Imperial College London, London.
ORCID-Profile: P Gabriel Steg, Ajay J Kirtane, Duk-Woo Park, Harvey D White, Andrejs Erglis
Förderung
- Bristol-Myers Squibb
- Janssen Research and Development
Zitieren
APA
Gibson, C. M., Steg, P. G., Bahit, M. C., Al-Lamee, R., Mehta, S. R., Mehran, R., Weitz, J. I., Goto, S., Nicolau, J. C., Lopes, R. D., Ge, J., Tasic, N., Angiolillo, D. J., Baron, S. J., Kirtane, A. J., Xavier, D., Yasuda, S., Lewis, B. S., Park, D. W., …, & Li, J. S. (2026). Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event. New England Journal of Medicine, 395(16), 1575-1584. https://doi.org/10.1056/nejmoa2608717
Vancouver
Gibson CM, Steg PG, Bahit MC, Al-Lamee R, Mehta SR, Mehran R, et al. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event. New England Journal of Medicine. 2026;395(16):1575-1584. doi:10.1056/nejmoa2608717
BibTeX
@article{Gibson2026,
author = {Gibson, C Michael and Steg, P Gabriel and Bahit, M Cecilia and Al-Lamee, Rasha and Mehta, Shamir R and Mehran, Roxana and Weitz, Jeffrey I and Goto, Shinya and Nicolau, Jose Carlos and Lopes, Renato D and Ge, Junbo and Tasic, Nebojsa and Angiolillo, Dominick J and Baron, Suzanne J and Kirtane, Ajay J and Xavier, Denis and Yasuda, Satoshi and Lewis, Basil S and Park, Duk-Woo and Cornel, Jan H and Johnson, Thomas W and Trebacz, Jaroslaw and Duerschmied, Daniel and Bode, Christoph and Merkely, Bela and Dorobantu, Maria and Vinereanu, Dragos and Motovska, Zuzana and Bueno, Hector and Lopez-Sendon, Jose Luis and Ducrocq, Gregory and Ambrosio, Giuseppe and Burgess, Lesley and Bohm, Allan and Chiang, Chern-En and Morais, Joao and Fong, Alan and Guray, Umit and Leiva-Pons, Jose Luis and Vranckx, Pascal and White, Harvey D and Kedev, Sasko and Valgimigli, Marco and Cerovec, Duško and Tousoulis, Dimitris and Figtree, Gemma and Ho, Thuong Dung and Sy, Rody G and Bøttcher, Morten and Huber, Kurt and Slapikas, Rimvydas and Erglis, Andrejs and Tan, Jack Wei Chieh and Pincetti, Christian and Pieper, Karen S and Mahaffey, Kenneth W and Lam, Carolyn S P and Johnston, S Claiborne and Hankey, Graeme J and Li, Jennifer S},
title = {Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {16},
pages = {1575--1584},
doi = {10.1056/nejmoa2608717}
}
EUVIMED